Sylvester Researchers Discover Possible Pathway for Immune Therapy in Pancreatic Cancer: University of Miami
November 05, 2019
November 05, 2019
MIAMI, Florida, Nov. 5 [TNSmedicalresearch-Journal of Clinical Investigation] -- The University of Miami's Miller School of Medicine issued the following news:
Immune therapy has not worked well in pancreatic cancer because of the cancer's inherent immune resistance. Sylvester Comprehensive Cancer Center scientists have discovered a way to outsmart the deadly cancer's ability to prevent immune checkpoint inhibitor therapy from killing pancreatic cancer cells.
"To b . . .
Immune therapy has not worked well in pancreatic cancer because of the cancer's inherent immune resistance. Sylvester Comprehensive Cancer Center scientists have discovered a way to outsmart the deadly cancer's ability to prevent immune checkpoint inhibitor therapy from killing pancreatic cancer cells.
"To b . . .